Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques
Fabiola Carrara, Flavio Gaspari, Matias Trillini, Tobia Peracchi, Diego Fidone, Nadia Stucchi, Silvia Ferrari, Daniela Cugini, Norberto Perico, Aneliya Parvanova, Giuseppe Remuzzi, Piero Ruggenenti (2024). GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques. , 19(7), DOI: https://doi.org/10.1371/journal.pone.0306935.
Article42 days agoReliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe Proteinuria
Carmine Zoccali, Pasquale Fabio Provenzano, Giovanni Tripepi, Fabiola Carrara, Francesca Mallamaci, Annalisa Perna, Pierre Delanaye, Piero Ruggenenti, Giuseppe Remuzzi (2024). Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe Proteinuria. , 20(2), DOI: https://doi.org/10.2215/cjn.0000000602.
Article42 days agoA GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals
Matteo Breno, Marina Noris, Nadia Rubis, Aneliya Parvanova, Davide Martinetti, Sara Gamba, Lucia Liguori, Caterina Mele, Rossella Piras, Silvia Orisio, Elisabetta Valoti, Marta Alberti, Olimpia Diadei, Elena Bresin, Miriam Rigoldi, Silvia Prandini, Tiziano Gamba, Nadia Stucchi, Fabiola Carrara, Erica Daina, Ariela Benigni, Giuseppe Remuzzi (2023). A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals. , 26(10), DOI: https://doi.org/10.1016/j.isci.2023.107629.
Article42 days agoEffects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial
Matias Trillini, Anna Caroli, Norberto Perico, Andrea Remuzzi, Paolo Brambilla, Giulia Villa, Annalisa Perna, Tobia Peracchi, Nadia Rubis, Davide Martinetti, Rosa Caruso, Valentina Fanny Leone, Daniela Cugini, Fabiola Carrara, Giuseppe Remuzzi, Piero Ruggenenti (2023). Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial. , 18(2), DOI: https://doi.org/10.2215/cjn.0000000000000049.
Article42 days agoSafety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM)
Norberto Perico, Giuseppe Remuzzi, Matthew D. Griffin, Paul Cockwell, Alexander P. Maxwell, Federica Casiraghi, Nadia Rubis, Tobia Peracchi, Alessandro Villa, Marta Todeschini, Fabiola Carrara, Bernadette A. Magee, Piero Ruggenenti, Stefano Rota, Laura Cappelletti, Veronica McInerney, Tomás P. Griffin, Md Nahidul Islam, Martino Introna, Olga Pedrini, Josée Golay, A. Finnerty, Jon Smythe, Willem E. Fibbe, Stephen J. Elliman, Timothy O’Brien (2023). Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM). , 34(10), DOI: https://doi.org/10.1681/asn.0000000000000189.
Article42 days ago